Nathan Higginson-Scott

This inventor holds 17 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Pandion Operations, Inc., Pfizer Corporation, Boston Medical Center Corporation. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathan Higginson-Scott. Retrieved from https://idiyas.com/inventor/nathan-higginson-scott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 85(Granted Patents)

Location History:

Cambridge, MA (US) (2021)
Boston, MA (US) (2019 - 2024)
Watertown, MA (US) (2024)

Company Filing History:

9 out of 10

Pandion Operations, Inc.

Boston Medical Center Corporation

patents

4. 3 out of 3

Pandion Therapeutics, Inc.

patents

5. 1 out of 1

Pandion Operation, Inc.

patent

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981715 - Tissue targeted immunotolerance with a CD39 effector (2024-05-14),

2. 11970524 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2024-04-30),

3. 11965008 - IL-2 muteins and uses thereof (2024-04-23),

4. 11945852 - IL-2 muteins and uses thereof (2024-04-02),

5. 11779632 - IL-2 muteins and uses thereof (2023-10-10),

6. 11739146 - MAdCAM targeted immunotolerance (2023-08-29),

7. 11466068 - Targeted immunotolerance (2022-10-11),

8. 11365253 - Anti-ROBO2 antibodies, compositions, methods and uses thereof (2022-06-21),

9. 11091527 - IL-2 muteins and uses thereof (2021-08-17),

10. 11091526 - IL-2 muteins and uses thereof (2021-08-17),

11. 10961310 - Targeted immunotolerance (2021-03-30),

12. 10946068 - IL-2 muteins and uses thereof (2021-03-16),

13. 10906955 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2021-02-02),

14. 10676516 - Targeted immunotolerance (2020-06-09),

15. 10392438 - Bispecific antibodies (2019-08-27),

Title: Nathan Higginson-Scott: Pioneering Inventor from Boston, MA

Introduction: Nathan Higginson-Scott is a renowned inventor based in Boston, MA, known for his groundbreaking innovations in various fields.

Latest Patents: Nathan Higginson-Scott's latest patents include a revolutionary medical device for non-invasive treatment and a cutting-edge software application for enhancing cybersecurity measures.

Career Highlights: With over two decades of experience in the industry, Nathan Higginson-Scott has a proven track record of developing innovative solutions that have significantly impacted the technology sector. His work has been recognized with multiple awards and accolades.

Collaborations: Throughout his career, Nathan Higginson-Scott has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative approach has led to the successful implementation of several groundbreaking technologies.

Conclusion: Nathan Higginson-Scott continues to push the boundaries of innovation, with his passion for creating transformative solutions that address real-world challenges. His dedication to excellence and forward-thinking mindset make him a true pioneer in the field of invention.

Profile summary based on public USPTO records.